MBio to Seek FDA Approval for LightDeck® Platform - Colorado Bioscience Association

This topic has 0 replies, 1 voice, and was last updated 4 years, 6 months ago by Natalie Allen.

Viewing 1 post (of 1 total)

Author

Posts
04/07/2020 at 1:43 pm #4287

Natalie Allen
Participant

Future Use in Outbreak Management Expected, via DARPA Partnership

Boulder, CO, April 6, 2020 – MBio Diagnostics today announced an expanded scope contract with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress towards FDA approval for MBio’s LightDeck® platform. Read more in MBio Diagnostic press release.
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.